Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biocon Limited ( (IN:BIOCON) ) just unveiled an update.
Biocon Limited has approved and adopted a placement document for a Qualified Institutions Placement (QIP) of equity shares with a face value of ₹5 each, in line with SEBI’s Issue of Capital and Disclosure Requirements Regulations and relevant provisions of the Companies Act, 2013. The move, cleared by the company’s Fund Raising Committee on January 14, 2026, marks a key procedural step toward raising institutional capital, which is expected to strengthen Biocon’s balance sheet and support its strategic growth plans in the competitive biopharmaceuticals market, while signaling continued engagement with institutional investors and public market funding avenues.
More about Biocon Limited
Biocon Limited is an India-based biopharmaceutical company headquartered in Bengaluru, operating in the life sciences and healthcare sector. It is engaged in the development, manufacture and commercialization of biologics, biosimilars and other pharmaceutical products for domestic and international markets, with its equity shares listed on BSE and the National Stock Exchange of India.
Average Trading Volume: 147,947
Technical Sentiment Signal: Buy
Current Market Cap: 496.5B INR
See more data about BIOCON stock on TipRanks’ Stock Analysis page.